![](/img/cover-not-exists.png)
A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions: 12-Month Outcomes From the ENDEAVOR IV Trial
Martin B. Leon, Laura Mauri, Jeffrey J. Popma, Donald E. Cutlip, Eugenia Nikolsky, Charles O'Shaughnessy, Paul A. Overlie, Brent T. McLaurin, Stuart L. Solomon, John S. Douglas Jr, Michael W. Ball, RoVolume:
55
Year:
2010
Language:
english
DOI:
10.1016/j.jacc.2009.08.067
File:
PDF, 923 KB
english, 2010